Adverse events of antihypertensive drugs in elderly
pdf

Keywords

arterial hypertension, elderly, adverse events, antihypertensive therapy.

How to Cite

Yena , L., Artemenko , V., & Akhaladze , M. (2020). Adverse events of antihypertensive drugs in elderly. The Journal of Neuroscience, 8(3-4), 5-9. Retrieved from https://neuroscience.com.ua/index.php/journal/article/view/349

Abstract

The issues of rational pharmacotherapy of arterial hypertension of the geriatric contingent are considered in the article. Emphasis is placed on the risk of adverse events depending on age, polymorbidity, polypharmacy, the presence of geriatric syndromes. The peculiarities of the development of adverse events in geriatric patients to antihypertensive drugs are discussed. The principles of antihypertensive therapy are provided, providing effective and safe medical treatment of patients with hypertension in the elderly and the very elderly.

pdf

References

1. Siddiqui M.H., Khan I.A. Essential Hypertension in the Elderly: To Treat or Not to Treat? A Therapeutic Dilemma for the Geriatric Cardiologis // Open. J. Carrdiol. Heart. Dis. — 2019. — Vol. 2, № 5. — Р. 1-9.
2. Давыдовский И.В. Геронтология. — М.: Медицина, 1966.
3. Musini V.M., Tejani A.M., Bassett K., Puil L., Wright J.M., Cochrane Hypertension Group // Cochrane Database Syst. Rev. — 2019 Jun. — 2019 (6): CD000028. Published online 2019 Jun 5. doi: 10.1002/14651858.CD000028.pub3
4. Staessen J.A., Gasowski J., Wang J.G., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials // Lancet. — 2000. — Vol. 355 (9207). — P. 865-872.
5. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data // Blood Pressure Lowering Treatment Trialists’
Collaboration Lancet. — 2014. — Vol. 384 (9943). — P. 591-598.
6. Siddiqui M.H., Khan I.A. Essential Hypertension in the Elderly: To Treat or Not to Treat? A Therapeutic Dilemma for the Geriatric Cardiologis // Open. J. Carrdiol. Heart. Dis. — 2019. — Vol. 2, № 5. — Р. 1-9.
7. van den Bussche H., Koller D., Kolonko T., et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany // BMC Public Health. — 2011. — Vol. 11. — P. 101.
8. Formiga F., Ferrer A., Sanz H., et al. Patterns of comorbidity and multimorbidity in the oldest old: The Octabaix study // Eur. J. Intern. Med. — 2013. — Vol. 24 (1). — P. 40-44.
9. Shan B., Haijar E. Polypharmacy, Adverse Drug Reaction, And Geriatric Syndrome // Clin. Geriatr. Med. — 2012. — Vol. 28. — P. 173-186.
10. Kang M.G., Kim S.W., Yoon S.J., et al. Association between frailty and hypertension prevalence, treatment, and control in the elderly Korean population // Sci.
Rep. — 2017. — Vol. 7. — P. 7542.
11. Rochorn P.A., Gurwitz J.H. The prescribing cascade revisited // The Lancet. — 2017. https://doi.org/10.1016/S0140-6736(17)31188-1
12. Gebreyohannes Eyob Alemayehu, Bhagavathula Akshaya Srikanth, Abebe Tamrat Befekadu, Tefera Yonas Getaye, Abegaz Tadesse Melaku. Adverse effects and nonadherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital // Clin. Hypertens. — 2019 Jan 15. — Vol. 25. — P. 1. doi: 10.1186/ s40885-018-0104-6.
13. Остроумова О.Д. Выбор антигипертензивного препарата для лечения артериальной гипертензии // Практична ангіологія. — 2014. — № 1 (64).
14. Mangoni A.A. and Jackson S.H.D. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications // Br. J. Clin.
Pharmacol. — 2004 Jan. — Vol. 57 (1). — P. 6-14.
15. Сastleden C.M., George C.F. The effect of ageing on the hepatic clearance of propranolol // Br. J. Clin. Pharmacol. — 1979. — Vol. 7. — P. 49-54.